GAURAV AGGARWAL

Profile

First Name

: GAURAV

Middle Name

:

Last Name

: AGGARWAL

Related Companies
Titles
Company Name
Related People
DIRECTOR
HYPERION THERAPEUTICS INC
DION COAKLEY, KLARA DICKINSON, KLARA A. DICKINSON, JEFFREY FARROW, JEFFREY S. FARROW, ASHLEY GOULD, DAVID GRYSKA, BO JESPER HANSEN, BO JESPER HANSEN, JAMES HEALY, JAMES I. HEALY, JIM HEALY, NATALIE HOLLES, ROB HOPFNER, ROBERT HOPFNER, TONI MARTINEZ, MASOUD MOKHTARANI, CHRISTINE NASH, CHRISTINE A. NASH, JAKE NUNN, JAKE R. NUNN, DANIEL PEREZ, BIJAN SALEHIZADEH, DON SANTEL, DONALD SANTEL, DONALD J. SANTEL, BRUCE SCHARSCHMIDT, BRUCE F. SCHARSCHMIDT, DANIEL G. WELCH, LOTA ZOTH, LOTA S. ZOTH
DIRECTOR
NEXTWAVE PHARMACEUTICALS INC
LINDA ARA, SALLY BERRY, MICHAEL BURDICK, ROBERT CASALE, CRAIG CHAMBLISS, STEVE ELMS, HINGGE HSU, FRANK KUNG, ANAND MEHRA, DAYTON MISFELDT, JAY SHEPARD, PATRICK ZENNER
DIRECTOR
AUSPEX PHARMACEUTICALS, INC.
DAVID COLLIER, ROD FERGUSON, LAWRENCE C. FRITZ, THOMAS GANT, R. GARY GILMORE, MICHAEL GREY, RON NEWBOLD, SAM SACHS, SAMUEL SAKS, SEP SARSHAR, SEPEHR SARSHAR, PRATIK SHAH, SEP SHARSHAR, ANDREAS SOMMER, ANDREAS SOMMERS, DAVID STAMLER, DAVID A. STAMLER, DAVID. A. STAMLER
EXECUTIVE OFFICER
VIVO OPPORTUNITY FUND, L.P.
ALBERT CHA, MICHAEL CHANG, KEVIN DAI, SHAN FU, FRANK KUNG, HONGBO LU, N/A VIVO OPPORTUNITY, LLC
EXECUTIVE OFFICER
VIVO OPPORTUNITY CO-INVEST, L.P.
ALBERT CHA, MICHAEL CHANG, SHAN FU, FRANK KUNG, N/A VIVO OPPORTUNITY, LLC
EXECUTIVE OFFICER
VIVO OPPORTUNITY CO-INVEST (W), L.P.
ALBERT CHA, MICHAEL CHANG, SHAN FU, FRANK KUNG, N/A VIVO OPPORTUNITY, LLC
DIRECTOR
UNICYCIVE THERAPEUTICS, INC.
SHALABH GUPTA, SARA KENKARE-MITRA, SANDEEP LAUMAS, JOHN RYAN, BRIGITTE SCHILLER, JOHN TOWNSEND
DIRECTOR
VIVO OPPORTUNITY CAYMAN FUND, L.P.
KEVIN DAI, SHAN FU, FRANK KUNG, N/A VIVO ASIA OPPORTUNITY, LLC, N/A VIVO OPPORTUNITY CAYMAN, LLC
DIRECTOR
VIVO CAPITAL FUND X, L.P.
MICHAEL CHANG, EDGAR ENGLEMAN, SHAN FU, FRANK KUNG, DAVID LIU, N/A VIVO CAPITAL X, LLC
DIRECTOR
BONUM THERAPEUTICS, INC.
SAMUEL BJORK, SAMUEL BLACKMAN, KARL HANDELSMAN, DIANE HOLLENBAUGH, JOHN MCKEARN, JOHN MULLIGAN, MITCHELL MUTZ, NEELA PATEL, MONIQUE SCHIERSING, NICHOLAS WALROD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-04-03 
2026-01-20
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2023-07-31 
2025-10-10
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2021-08-26 
2025-09-02
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2021-09-28 
2025-01-08
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2023-07-31 
2024-10-10
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2021-08-26 
2024-07-08
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2021-09-28 
2024-03-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-03-13 
2023-03-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-03-03 
2022-03-24
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2021-09-28 
2019-05-08
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2019-05-02 
2019-04-19
D
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2019-04-18 
2018-08-31
D/A
Link
PRIVATE EQUITY FUND 
 
DECLINE TO DISCLOSE 
 
2017-12-27 
2012-11-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-10-31 
2011-11-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-10-26 
2011-04-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-04-01 
2011-01-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-10 
2009-07-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-29